Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry

Molecular Pharmacology

Volumn 58, Issue 5, 2000, Pages 1042-1049

  Newman Tancredi, Adrian ^a   Audinot, Valérie ^a   Moreira, Celia ^a   Verrièle, Laurence ^a   Millan, Mark J ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; 5 FLUORO 3 [3 [4 (5 METHOXY 4 PYRIMIDINYL) 1 PIPERAZINYL]PROPYL] 1H INDOLE; GUANINE NUCLEOTIDE BINDING PROTEIN; METITEPINE; SEROTONIN; SEROTONIN 1B RECEPTOR; SUMATRIPTAN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; STOICHIOMETRY;

EID: 0033790260     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.5.1042     Document Type: Article

References (40)

1. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine(1B) receptor expression system
2. 35S]-GTPγS binding at h5-HT(1D) receptors expressed in CHO cells
3. 35S]-GTPγS binding isotherms
4. Signal transduction by G proteins: 1994 edition
5. 35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity
6. Autoradiographic characterisation and localisation of 5-HT(1D) compared to 5-HT(1B) binding sites in rat brain. Naunyn-Schmiedeberg's
7. Constitutive activation of muscarinic receptors by the G-pretein G(q)
8. 3H]-GR125, 743, a novel radiolabelled serotonin 5-HT(1B) receptor antagonist. Naunyn-Schmiedeberg's
9. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT(1B) binding sites. Naunyn-Schmiedeberg's
10. Effector coupling mechanisms of the cloned 5-HT(1A) receptor
11. The selective 5-HT(1B) receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]-2,3, 6,7-tetrahydro-spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function bath in vitro and in vivo
12. 4.4 receptors expressed in CHO cells
13. 35S]-GTPγS binding to cortical membranes from post-mortem human brain
14. Functional and structural complexity of signal transduction via G-protein-coupled receptors
15. 5-HT(1D) receptors: Pharmacology and therapeutic potential
16. Alignment of receptor nomenclature with the human genome: Classification of 5-HT(1B) and 5-HT(1D) receptor subtypes
17. Pharmacologic Analysis of Drug-Receptor Interactions. Lippincett-Raven, Philadelphia, PA. Kenakin T (1997b) Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry
18. 4
19. The two-state model of receptor activation
20. Comparison of the vasoconstrictor effects of the selective 5-HT(1D)-receptor antagonist L-775,606 with the mixed 5-HT(1B/1D)-receptor agonist sumatriptan and 5-HT in human isolated coronary artery
21. 35S]thio)triphosphate binding
22. The induction of pain: An integrative review
23. Inverse agonists and serotonergic transmission: From recombinant human 5-HT(1A) and 5-HT(1B) receptors to quantification of G-protein coupling and function in corticolimbic structures
24. Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT(1A) receptors as a function of receptor:G-protein stoichiometry
25. 4 and serotonin 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptors. Naunyn-Schmiedeberg's
26. 35S]GTPγS binding and antibody study
27. 4 receptor
28. How efficacious are the 5-HT(1B/D) receptor ligands: An answer from GTPγS binding studies with stably transfected C6-glial cell lines
29. 373Lys) and Go protein coexpression: Evidence for inverse agonism
30. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT(1B) receptors in C6-glial cells: Similarities with the human 5-HT(1B) receptor
31. Samatriptan: A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache
32. Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor
33. Cellular and subcellular localisation of 5-hydroxytryptamine1B receptors in the rat central nervous system: Immunechemical, autoradiographic and lesion studies
34. Inhibition of cAMP accumulation via recombinant human serotenin 5-HT(1A) receptors: Considerations on receptor effector coupling across systems
35. SB-224289 a novel selective (human) 5-HT(1B) receptor antagonist with negative intrinsic activity
36. 35S]GTPγS binding in mMORCHO cells and rat thalamus
37. 35S]GTPγS binding to CHO cell membranes expressing human 5-HT(1B) receptors: Evidence for negative efficacy of 5-HT receptor antagonists
38. Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: Effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase
39. 2-dopamine receptor of the anterior pituitary glad
40. Pharmacological characterizations of recombinant human 5-HT(1Dα) and 5-HT(1Dβ) receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: Apparent differences in drug intrinsic efficacies between human 5-HT(1D) subtypes. Naunyn-Schmiedeberg's